Article ID Journal Published Year Pages File Type
10745815 Parkinsonism & Related Disorders 2013 6 Pages PDF
Abstract
Simvastatin reduced dyskinesia in primates using high doses over 3 mg/kg but the exploratory trial in patients revealed no effect at 40 mg/d suggesting that higher doses, not compatible with a safe prolonged administration, are necessary.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Ageing
Authors
, , , , , , , , , , , , , ,